Bringing innovative trials to the UKWe spoke with the National Institute for Health Research’s (NIHR) senior business development manager, Anjna Rising, to learn Share XBringing innovative trials to the UKhttps://pharmaphorum.com/r-d/views-analysis-r-d/bringing-innovative-trials-to-the-uk/
Patients in the driving seatMany pharma companies talk about the importance of ‘patient centric’ clinical trials and involving patients in trial design – Share XPatients in the driving seathttps://pharmaphorum.com/r-d/patients-in-the-driving-seat/
The state of UK drug discovery: the pharmaphorum podcastThe UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role Share XThe state of UK drug discovery: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/medicines-discovery-catapult-uk-drug-discovery/
Keeping clinical trials on trackEver felt like you ended up somewhere unexpected, not quite knowing what path you took to get there? Share XKeeping clinical trials on trackhttps://pharmaphorum.com/r-d/keeping-clinical-trials-on-track/
The future of clinical trials innovationMedidata is engaging with regulators to advise on the future of clinical trials, but CEO Tarek Sherif cautions Share XThe future of clinical trials innovationhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-future-of-clinical-trials-innovation/
Deep Dive: Oncology and ASCO 2019Oncology is currently a more cutting-edge, dynamic field than it has ever been – as demonstrated at this Share XDeep Dive: Oncology and ASCO 2019https://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019
Alexion Pharmaceuticals & Minoryx Therapeutics to Present at SMi’s Orphan Drugs EventSMi Reports: Alexion Pharmaceuticals and Minoryx Therapeutics to deliver presentations at the 9th Annual Orphan Drugs and Rare Share XAlexion Pharmaceuticals & Minoryx Therapeutics to Present at SMi’s Orphan Drugs Eventhttps://pharmaphorum.com/partner-content/alexion-pharmaceuticals-minoryx-therapeutics-to-present-at-smis-orphan-drugs-event/
Digital tool aims to cut costs and risks of underperforming trialsArcheMedx, which provides tech solutions for life sciences and healthcare, has launched a new digital service that aims Share XDigital tool aims to cut costs and risks of underperforming trialshttps://pharmaphorum.com/news/digital-tool-aims-to-cut-costs-and-risks-of-underperforming-trials/
The importance of virtual trials for patient engagementHow virtual trials help diminish barriers to participation and make clinical research easier for patients. When we talk Share XThe importance of virtual trials for patient engagementhttps://pharmaphorum.com/views-and-analysis/the-importance-of-virtual-trials-for-patient-engagement/
